Specialty Generics Market Report

Specialty Generics Market Analysis By Type (Injectables, Oral), By Application (Oncology, Inflammatory Conditions, Multiple Sclerosis, Hepatitis C), By End-use, And Segment Forecasts, 2018 - 2025

  • Published Date: Sep 2017
  • Report ID: GVR-1-68038-629-5
  • Number of Pages: 101
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016

Table of Contents

Chapter 1 Research Methodology
                 1.1 Country Wise Market: Base Estimates
                 1.2 Global Market: CAGR Calculation
                 1.3 Region-Based Segment Share Calculation
                 1.4 Research Scope & Assumptions
                 1.5 List of Data Sources
                     1.5.1 Data for primary interviews, by sources
Chapter 2 Executive Summary
                 2.1 Market Snapshot
Chapter 3 Specialty Generics Market Variables, Trends & Scope
                 3.1 Market Segmentation & Scope
                 3.2 Market Driver Analysis
                     3.2.1 Rising number of off-patent specialty drugs
                     3.2.2 Escalating demand for low cost generic specialty drugs
                     3.2.3 Increasing prevalence of chronic diseases
                     3.2.4 Increasing emphasis to cut down healthcare expenditures
                 3.3 Market Restraint Analysis
                     3.3.1 Rigorous regulatory governance in countries
                     3.3.2 Delay in new drug launches
                 3.4 Key Opportunities Prioritized
                     3.4.1 Key opportunities prioritized, by type
                 3.5 Specialty Generic Drugs - SWOT Analysis, By Factor (political & legal, economic and technological)
                 3.6 Industry Analysis - Porter’s
                 3.7 Specialty Generics Market: Market Position Analysis
Chapter 4 Specialty Generics Market: Type Estimates & Trend Analysis
                 4.1 Specialty Generics Market: Type Movement Analysis
                 4.2 Injectables
                     4.2.1 Injectables market, 2014 - 2025 (USD Billion)
                 4.3 Oral Drugs
                     4.3.1 Oral drugs market, 2014 - 2025 (USD Billion)
                 4.4 Others
                     4.4.1 Others market, 2014 - 2025 (USD Billion)
Chapter 5 Specialty Generics Market: Application Estimates & Trend Analysis
                 5.1 Specialty Generics Market: Application Movement Analysis
                 5.2 Oncology
                     5.2.1 Oncology market, 2014 - 2025 (USD Billion)
                 5.3 Inflammatory Conditions
                     5.3.1 Inflammatory conditions market, 2014 - 2025 (USD Billion)
                 5.4 Multiple Sclerosis
                     5.4.1 Multiple sclerosis market, 2014 - 2025 (USD Billion)
                 5.5 Hepatitis C
                     5.5.1 Hepatitis C market, 2014 - 2025 (USD Billion)
                 5.6 Others
                     5.6.1 Others market, 2014 - 2025 (USD Billion)
Chapter 6 Specialty Generics Market: End-use Estimates & Trend Analysis
                 6.1 Specialty Generics Market: End Use Movement Analysis
                 6.2 Specialty Pharmacy
                     6.2.1 Specialty pharmacy market, 2014 - 2025 (USD Billion)
                 6.3 Retail Pharmacy
                     6.3.1 Retail pharmacy market, 2014 - 2025 (USD Billion)
                 6.4 Hospital Pharmacy
                     6.4.1 Hospital pharmacy market, 2014 - 2025 (USD Billion)
Chapter 7 Specialty Generics Market: Regional Estimates & Trend Analysis, by Type, Application, End-use
                 7.1 Specialty Generics Market Share by Region, 2016 & 2025
                 7.2 North America
                     7.2.1 The U.S.
                         7.2.1.1 U.S. specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.2.1.2 U.S. specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.2.1.3 U.S. specialty generics market, by end use, 2014 - 2025 (USD Billion)
                     7.2.2 Canada
                         7.2.2.1 Canada specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.2.2.2 Canada specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.2.2.3 Canada specialty generics market, by end use, 2014 - 2025 (USD Billion)
                 7.3 Europe
                     7.3.1 Germany
                         7.3.1.1 Germany specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.3.1.2 Germany specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.3.1.3 Germany specialty generics market, by end use, 2014 - 2025 (USD Billion)
                     7.3.2 The U.K.
                         7.3.2.1 U.K. specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.3.2.2 U.K. specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.3.2.3 U.K. specialty generics market, by end use, 2014 - 2025 (USD Billion)
                     7.3.3 France
                         7.3.3.1 France specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.3.3.2 France specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.3.3.3 France specialty generics market, by end use, 2014 - 2025 (USD Billion)
                     7.3.4 Italy
                         7.3.4.1 Italy specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.3.4.2 Italy specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.3.4.3 Italy specialty generics market, by end use, 2014 - 2025 (USD Billion)
                     7.3.5 Spain
                         7.3.5.1 Spain specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.3.5.2 Spain specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.3.5.3 Spain specialty generics market, by end-use, 2014 - 2025 (USD Billion)
                 7.4 Asia Pacific
                     7.4.1 Japan
                         7.4.1.1 Japan specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.4.1.2 Japan specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.4.1.3 Japan specialty generics market, by end-use, 2014 - 2025 (USD Billion)
                     7.4.2 China
                         7.4.2.1 China specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.4.2.2 China specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.4.2.3 China specialty generics market, by end-use, 2014 - 2025 (USD Billion)
                     7.4.3 India
                         7.4.3.1 India specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.4.3.2 India specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.4.3.3 India specialty generics market, by end-use, 2014 - 2025 (USD Billion)
                 7.5 Latin America
                     7.5.1 Brazil
                         7.5.1.1 Brazil specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.5.1.2 Brazil specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.5.1.3 Brazil specialty generics market, by end-use, 2014 - 2025 (USD Billion)
                     7.5.2 Mexico
                         7.5.2.1 Mexico specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.5.2.2 Mexico specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.5.2.3 Mexico specialty generics market, by end-use, 2014 - 2025 (USD Billion)
                 7.6 MEA
                     7.6.1 South Africa
                         7.6.1.1 South Africa specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.6.1.2 South Africa specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.6.1.3 South Africa specialty generics market, by end-use, 2014 - 2025 (USD Billion)
                     7.6.2 Saudi Arabia
                         7.6.2.1 Saudi Arabia specialty generics market, by type, 2014 - 2025 (USD Billion)
                         7.6.2.2 Saudi Arabia specialty generics market, by application, 2014 - 2025 (USD Billion)
                         7.6.2.3 Saudi Arabia specialty generics market, by end-use, 2014 - 2025 (USD Billion)
Chapter 8 Competitive Landscape
                 8.1 Company Profiles
                     8.1.1 Teva Pharmaceuticals USA, Inc.
                         8.1.1.1 Company Overview
                         8.1.1.2 Financial Performance
                         8.1.1.3 Product Benchmarking
                         8.1.1.4 Strategic Initiatives
                     8.1.2 Mylan N.V.
                         8.1.2.1 Company Overview
                         8.1.2.2 Financial Performance
                         8.1.2.3 Product Benchmarking
                         8.1.2.4 Strategic Initiatives
                     8.1.3 Sandoz International GmbH
                         8.1.3.1 Company Overview
                         8.1.3.2 Financial Performance
                         8.1.3.3 Product Benchmarking
                         8.1.3.4 Strategic Initiatives
                     8.1.4 Akorn, Inc.
                         8.1.4.1 Company Overview
                         8.1.4.2 Financial Performance
                         8.1.4.3 Product Benchmarking
                     8.1.5 Mallinckrodt
                         8.1.5.1 Company Overview
                         8.1.5.2 Financial Performance
                         8.1.5.3 Product Benchmarking
                     8.1.6 Valeant Pharmaceuticals International, Inc.
                         8.1.6.1 Company Overview
                         8.1.6.2 Financial Performance
                         8.1.6.3 Product Benchmarking
                         8.1.6.4 Strategic Initiatives
                     8.1.7 Pfizer Inc.
                         8.1.7.1 Company Overview
                         8.1.7.2 Financial Performance
                         8.1.7.3 Product Benchmarking
                         8.1.7.4 Strategic Initiatives
                     8.1.8 Endo Pharmaceuticals Inc.
                         8.1.8.1 Company Overview
                         8.1.8.2 Financial Performance
                         8.1.8.3 Product Benchmarking
                         8.1.8.4 Strategic Initiatives
                     8.1.9 Apotex Corp.
                         8.1.9.1 Company Overview
                         8.1.9.2 Product Benchmarking
                     8.1.10 Sun Pharmaceutical Industries Ltd.
                         8.1.10.1 Company Overview
                         8.1.10.2 Financial Performance
                         8.1.10.3 Product Benchmarking
                         8.1.10.4 Strategic Initiatives


List of Tables

TABLE 1 Factors used in segment share estimation
TABLE 2 List of secondary data sources
TABLE 3 North America specialty generics market, by country, 2014 - 2025 (USD Billion)
TABLE 4 North America specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 5 North America specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 6 North America specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 7 U.S. specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 8 U.S. specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 9 U.S. specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 10 Canada specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 11 Canada specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 12 Canada specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 13 Europe specialty generics market, by country, 2014 - 2025 (USD Billion)
TABLE 14 Europe specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 16 Europe specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 17 Europe specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 18 Germany specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 19 Germany specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 20 Germany specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 21 U.K. specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 22 U.K. specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 23 U.K. specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 24 France specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 25 France specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 26 France specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 27 Italy specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 28 Italy specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 29 Italy specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 30 Spain specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 31 Spain specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 32 Spain specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 33 Asia Pacific specialty generics market, by country, 2014 - 2025 (USD Billion)
TABLE 34 Asia Pacific specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 35 Asia Pacific specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 36 Asia Pacific specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 37 Japan specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 38 Japan specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 39 Japan specialty generics market, by end use, 2014 - 2025 (USD Billion)
TABLE 40 China specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 41 China specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 42 China specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 43 India specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 44 India specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 45 India specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 46 Latin America specialty generics market, by country, 2014 - 2025 (USD Billion)
TABLE 47 Latin America specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 48 Latin America specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 49 Latin America specialty generics market, by end use, 2014 - 2025 (USD Billion)
TABLE 50 Brazil specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 51 Brazil specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 52 Brazil specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 53 Mexico specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 54 Mexico specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 55 Mexico specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 56 MEA specialty generics market, by country, 2014 - 2025 (USD Billion)
TABLE 57 MEA specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 58 MEA specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 59 MEA specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 60 South Africa specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 61 South Africa specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 62 South Africa specialty generics market, by end-use, 2014 - 2025 (USD Billion)
TABLE 63 Saudi Arabia specialty generics market, by type, 2014 - 2025 (USD Billion)
TABLE 64 Saudi Arabia specialty generics market, by application, 2014 - 2025 (USD Billion)
TABLE 65 Saudi Arabia specialty generics market, by end-use, 2014 - 2025 (USD Billion)


List of Figures

FIG. 1 Primary interviews, by sources
FIG. 2 Primary interviews, by region
FIG. 3 Market summary
FIG. 4 Market trends & outlook
FIG. 5 Market segmentation & scope
FIG. 6 Market driver relevance analysis (Current & future impact)
FIG. 7 Market restraint relevance analysis (Current & future impact)
FIG. 8 Regulatory Guidelines For Generic Medicines
FIG. 9 Key opportunities prioritized, by type
FIG. 10 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 11 Porter’s Five Forces Analysis
FIG. 12 Company market position analysis, 2016
FIG. 13 Specialty generics market, type outlook: Key takeaways
FIG. 14 Specialty generics market: Type movement analysis
FIG. 15 Injectables market, 2014 - 2025 (USD Billion)
FIG. 16 Oral drugs market, 2014 - 2025 (USD Billion)
FIG. 17 Others market, 2014 - 2025 (USD Billion)
FIG. 18 Specialty generics market, application outlook: Key takeaways
FIG. 19 Specialty generics market: Application movement analysis
FIG. 20 Oncology market, 2014 - 2025 (USD Billion)
FIG. 21 Inflammatory conditions market, 2014 - 2025 (USD Billion)
FIG. 22 Multiple sclerosis market, 2014 - 2025 (USD Billion)
FIG. 23 Hepatitis C market, 2014 - 2025 (USD Billion)
FIG. 24 Others market, 2014 - 2025 (USD Billion)
FIG. 25 Specialty generics market, end use outlook: Key takeaways
FIG. 26 Specialty generics market: End use movement analysis
FIG. 27 Specialty pharmacy market, 2014 - 2025 (USD Billion)
FIG. 28 Retail pharmacy market, 2014 - 2025 (USD Billion)
FIG. 29 Hospital pharmacy market, 2014 - 2025 (USD Billion)
FIG. 30 Regional market place: Key takeaways
FIG. 31 Regional outlook, 2016 & 2025

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.